EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 253 filers reported holding EMERGENT BIOSOLUTIONS INC in Q4 2021. The put-call ratio across all filers is 0.83 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $34,014 | -53.7% | 10,004 | 0.0% | 0.02% | -47.6% |
Q2 2023 | $73,529 | -29.1% | 10,004 | 0.0% | 0.04% | -33.3% |
Q1 2023 | $103,641 | -12.3% | 10,004 | 0.0% | 0.06% | -25.0% |
Q4 2022 | $118,147 | -43.7% | 10,004 | 0.0% | 0.08% | -52.0% |
Q3 2022 | $210,000 | -32.5% | 10,004 | 0.0% | 0.18% | -28.6% |
Q2 2022 | $311,000 | -24.3% | 10,004 | 0.0% | 0.24% | -9.3% |
Q1 2022 | $411,000 | -5.5% | 10,004 | 0.0% | 0.27% | -2.2% |
Q4 2021 | $435,000 | -13.2% | 10,004 | 0.0% | 0.28% | -18.8% |
Q3 2021 | $501,000 | -20.5% | 10,004 | 0.0% | 0.34% | -15.8% |
Q2 2021 | $630,000 | -32.2% | 10,004 | 0.0% | 0.40% | -29.0% |
Q1 2021 | $929,000 | -10.2% | 10,004 | 0.0% | 0.57% | -30.2% |
Q4 2020 | $1,034,000 | 0.0% | 10,004 | 0.0% | 0.82% | +0.7% |
Q3 2020 | $1,034,000 | – | 10,004 | – | 0.81% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SNYDER CAPITAL MANAGEMENT L P | 1,031,859 | $59,703,000 | 3.40% |
Laurus Investment Counsel Inc. | 74,169 | $4,291,000 | 3.10% |
Hillcrest Asset Management LLC | 220,660 | $12,767,000 | 3.07% |
RICE HALL JAMES & ASSOCIATES, LLC | 765,202 | $44,275,000 | 2.47% |
Tygh Capital Management, Inc. | 142,732 | $8,258,000 | 1.85% |
EARNEST PARTNERS LLC | 2,782,776 | $161,011,000 | 1.81% |
Pier Capital, LLC | 93,603 | $5,416,000 | 1.20% |
Portolan Capital Management | 131,659 | $7,618,000 | 1.14% |
Phocas Financial Corp. | 92,759 | $5,367,000 | 1.08% |
Consolidated Investment Group LLC | 37,000 | $2,141,000 | 0.94% |